Prot #BGB-11417-101: A Phase 1/1b Open-Label Dose Escalation and Expansion Study of Bcl-2 Inhibitor BGB-11417 in Patients with Mature B-Cell Malignancies

Project: Research project

Status	Active
Effective start/end date	8/5/21 → 8/5/24

Project Details